Cargando…

Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms

BACKGROUND: This study examined associations of abdominal adiposity with lung function, asthma symptoms and current doctor-diagnosed asthma and mediation by insulin resistance (IR) and sleep disordered breathing (SDB). METHODS: A random sample of 2500 households was drawn from the community of Whyal...

Descripción completa

Detalles Bibliográficos
Autores principales: Haren, Matthew T, Misan, Gary, Paterson, Tracey-Jayne, Ruffin, Richard E, Grant, Janet F, Buckley, Jonathan D, Howe, Peter RC, Newbury, Jonathan, Taylor, Anne W, McDermott, Robyn A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544645/
https://www.ncbi.nlm.nih.gov/pubmed/22742416
http://dx.doi.org/10.1186/1471-2466-12-31
_version_ 1782255814958907392
author Haren, Matthew T
Misan, Gary
Paterson, Tracey-Jayne
Ruffin, Richard E
Grant, Janet F
Buckley, Jonathan D
Howe, Peter RC
Newbury, Jonathan
Taylor, Anne W
McDermott, Robyn A
author_facet Haren, Matthew T
Misan, Gary
Paterson, Tracey-Jayne
Ruffin, Richard E
Grant, Janet F
Buckley, Jonathan D
Howe, Peter RC
Newbury, Jonathan
Taylor, Anne W
McDermott, Robyn A
author_sort Haren, Matthew T
collection PubMed
description BACKGROUND: This study examined associations of abdominal adiposity with lung function, asthma symptoms and current doctor-diagnosed asthma and mediation by insulin resistance (IR) and sleep disordered breathing (SDB). METHODS: A random sample of 2500 households was drawn from the community of Whyalla, South Australia (The Whyalla Intergenerational Study of Health, WISH February 2008 - July 2009). Seven-hundred twenty-two randomly selected adults (≥18 years) completed clinical protocols (32.2% response rate). Lung function was measured by spirometry. Post-bronchodilator FEV(1)/FVC was used to measure airway obstruction and reversibility of FEV(1) was calculated. Current asthma was defined by self-reported doctor-diagnosis and evidence of currently active asthma. Symptom scores for asthma (CASS) and SDB were calculated. Intra-abdominal fat (IAF) was estimated using dual-energy x-ray absorptiometry (DXA). IR was calculated from fasting glucose and insulin concentrations. RESULTS: The prevalence of current doctor-diagnosed asthma was 19.9% (95% CI 16.7 – 23.5%). The ratio of observed to expected cases given the age and sex distribution of the population was 2.4 (95%CI 2.1, 2.9). IAF was not associated with current doctor-diagnosed asthma, FEV(1)/FVC or FEV(1) reversibility in men or women but was positively associated with CASS independent of IR and SDB in women. A 1% increase in IAF was associated with decreases of 12 mL and 20 mL in FEV(1) and FVC respectively in men, and 4 mL and 7 mL respectively in women. SDB mediated 12% and 26% of these associations respectively in men but had minimal effects in women. CONCLUSIONS: In this population with an excess of doctor-diagnosed asthma, IAF was not a major factor in airway obstruction or doctor-diagnosed asthma, although women with higher IAF perceived more severe asthma symptoms which did not correlate with lower FEV(1). Higher IAF was significantly associated with lower FEV(1) and FVC and in men SDB mechanisms may contribute up to one quarter of this association.
format Online
Article
Text
id pubmed-3544645
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35446452013-01-16 Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms Haren, Matthew T Misan, Gary Paterson, Tracey-Jayne Ruffin, Richard E Grant, Janet F Buckley, Jonathan D Howe, Peter RC Newbury, Jonathan Taylor, Anne W McDermott, Robyn A BMC Pulm Med Research Article BACKGROUND: This study examined associations of abdominal adiposity with lung function, asthma symptoms and current doctor-diagnosed asthma and mediation by insulin resistance (IR) and sleep disordered breathing (SDB). METHODS: A random sample of 2500 households was drawn from the community of Whyalla, South Australia (The Whyalla Intergenerational Study of Health, WISH February 2008 - July 2009). Seven-hundred twenty-two randomly selected adults (≥18 years) completed clinical protocols (32.2% response rate). Lung function was measured by spirometry. Post-bronchodilator FEV(1)/FVC was used to measure airway obstruction and reversibility of FEV(1) was calculated. Current asthma was defined by self-reported doctor-diagnosis and evidence of currently active asthma. Symptom scores for asthma (CASS) and SDB were calculated. Intra-abdominal fat (IAF) was estimated using dual-energy x-ray absorptiometry (DXA). IR was calculated from fasting glucose and insulin concentrations. RESULTS: The prevalence of current doctor-diagnosed asthma was 19.9% (95% CI 16.7 – 23.5%). The ratio of observed to expected cases given the age and sex distribution of the population was 2.4 (95%CI 2.1, 2.9). IAF was not associated with current doctor-diagnosed asthma, FEV(1)/FVC or FEV(1) reversibility in men or women but was positively associated with CASS independent of IR and SDB in women. A 1% increase in IAF was associated with decreases of 12 mL and 20 mL in FEV(1) and FVC respectively in men, and 4 mL and 7 mL respectively in women. SDB mediated 12% and 26% of these associations respectively in men but had minimal effects in women. CONCLUSIONS: In this population with an excess of doctor-diagnosed asthma, IAF was not a major factor in airway obstruction or doctor-diagnosed asthma, although women with higher IAF perceived more severe asthma symptoms which did not correlate with lower FEV(1). Higher IAF was significantly associated with lower FEV(1) and FVC and in men SDB mechanisms may contribute up to one quarter of this association. BioMed Central 2012-06-28 /pmc/articles/PMC3544645/ /pubmed/22742416 http://dx.doi.org/10.1186/1471-2466-12-31 Text en Copyright ©2012 Haren et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Haren, Matthew T
Misan, Gary
Paterson, Tracey-Jayne
Ruffin, Richard E
Grant, Janet F
Buckley, Jonathan D
Howe, Peter RC
Newbury, Jonathan
Taylor, Anne W
McDermott, Robyn A
Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
title Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
title_full Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
title_fullStr Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
title_full_unstemmed Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
title_short Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
title_sort abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanisms
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544645/
https://www.ncbi.nlm.nih.gov/pubmed/22742416
http://dx.doi.org/10.1186/1471-2466-12-31
work_keys_str_mv AT harenmatthewt abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT misangary abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT patersontraceyjayne abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT ruffinricharde abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT grantjanetf abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT buckleyjonathand abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT howepeterrc abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT newburyjonathan abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT taylorannew abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms
AT mcdermottrobyna abdominaladiposityandobstructiveairwaydiseasetestinginsulinresistanceandsleepdisorderedbreathingmechanisms